News

Clinox

1st July 2007

All News | Technology News

In June 2007 Oxford University spun out a new company called Clinox from the Department of Clinical Pharmacology. Clinox offers pharmaceutical and biotechnology companies knowledge and expertise in the development, placement and conduct of early phase clinical trials with a particular focus in oncology.

Oxford Immunotec wins award

4th May 2007

All News | Technology News

Over 100 representatives from the business, technology, research and investment communities in Oxfordshire and beyond gathered at the Said Business School last night as the winners of the Martin and Audrey Wood Enterprise Awards 2007 were chosen.

Three Dimensional Light Microscopy – Amarel

1st March 2007

All News | Technology News

A technique which enabled light microscopy to produce an in-focus image of a three-dimensional structure at all depths would be extremely valuable.

Isis Enterprise Oxford – Alicia Martinez

1st February 2007

All News | Partners

In September 2006 I arrived from Valencia. I came to Oxford to work at Oxford University Innovation Ltd as a ‘secondee’ for six months.

Dendritic Cells in Vaccine Delivery & Human Embryoonic Stem Cell Therapies

1st February 2007

All News | Technology News

In March 2006 Geron Corporation entered into a worldwide exclusive licence agreement covering patent applications describing a method for generating dendritic cells from human embryonic stem cells. In a linked research agreement, Geron will fund work in the University’s Sir William Dunn School of Pathology to further develop the technology under the guidance of Dr. Paul Fairchild and Professor Herman Waldmann.

US patent – 100th granted to Oxford University Innovation Ltd.

14th January 2007

All News | Technology News

Oxford University Innovation Ltd, the leading technology transfer company, has been granted its 100th Patent from the US Patent Office.

BioSleep: Demonstrating the Continuum

30th November 2006

All News | Spinouts & Startups | Technology News

A paper appearing in EMBC¹ reports a major advance in the study of sleep disorders. Oxford BioSignals, a spin-out company from Oxford University, has developed and validated BioSleep, a novel system based on neural network analysis, which not only elucidates the microstructure of sleep - fleeting changes which have never before been consistently demonstrated - but also reliably detects abnormal sleep patterns.

The Low Carbon Incubator Programme – Isis is Partner

27th November 2006

All News | Technology News

Isis is partnering with the Carbon Trust to create a clean energy incubator whose purpose is to increase the likelihood of successfully commercialising technologies with carbon saving potential.

OxTox Ltd to Improve Road Safety

14th November 2006

All News | Spinouts & Startups | Technology News

The 64th spin-out company from the University of Oxford, OxTox Ltd, will produce drug-testing kits for the police to use on drivers that are as reliable and easy to use as breathalysers for alcohol.

Oxonica among the ‘best nanotechs’

10th November 2006

All News | Spinouts & Startups | Technology News

Oxonica has been named one of four nanotechnology startups offering the greatest value for potential corporate partners.

News

Ready to get in touch?